Effect of sodium nitroprusside on complement activation induced by cardiopulmonary bypass: A clinical and experimental study

Journal of Thoracic and Cardiovascular Surgery

Volumn 111, Issue 4, 1996, Pages 882-892

  Seghaye, M C ^a   Duchateau, J ^a   Grabitz, R G ^a   Wolff, T ^a   Marcus, C ^a   Engelhardt, W ^a   Hornchen, H ^a   Messmer, B J ^a   Von Bernuth, G ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; NITROPRUSSIDE SODIUM;

ARTICLE; CARDIOPULMONARY BYPASS; CHILD; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; INFANT; LEUKOCYTE COUNT; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0029921123     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(96)70350-1     Document Type: Article

References (43)

1. J Butler GM Rocker S. Westaby Inflammatory response to cardiopulmonary bypass Ann Thorac Surg 55 1993 552 559
2. SC Donnelly C Haslett I Dransfield Role of selectins in development of adult respiratory distress syndrome Lancet 344 1994 215 219
3. SKA Law KBM. Reid Activation and control of the complement system D Male D Rickwood Complement 1988 : IRL Press Oxford 9 27
4. NE Moat DF Shore TW. Evans Organ dysfunction and cardiopulmonary bypass: the role of complement and complement regulatory proteins Eur J Cardiothorac Surg 7 1993 563 573
5. JK Kirklin S Westaby EH Blackstone Complement and the damaging effects of cardiopulmonary bypass J Thorac Cardiovasc Surg 86 1983 845 857
6. DE Chenoweth SW Cooper TE Hugli Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins N Engl J Med 304 1981 497 503
7. DE Hammerschmidt DF Stroncek TK Bowers Complement activation and neutropenia occurring during cardiopulmonary bypass J Thorac Cardiovasc Surg 81 1981 370 377
8. JB Steinberg DP Kapelanski JD Olson Cytokine and complement levels in patients undergoing cardiopulmonary bypass J Thorac Cardiovasc Surg 106 1993 1008 1016
9. N Haeffner-Cavaillon N Rousselier O Ponzio Induction of interleukin-1 production in patients undergoing cardiopulmonary bypass J Thorac Cardiovasc Surg 98 1989 1100 1106
10. J Butler R Pillai GM Rocker Effect of cardiopulmonary bypass on systemic release of neutrophil elastase and tumor necrosis factor J Thorac Cardiovasc Surg 105 1993 25 30
11. NC Cavarocchi MD England HV Schaff Oxygen free radical generation during cardiopulmonary bypass: correlation with complement activation Circulation 74 Suppl 1986 III130 III133
12. W Scholz ML McClurg GJ Cardenas C5a-mediated release of interleukin 6 by human monocytes Clin lmmunol lmmunopathol 57 1990 297 307
13. MC Seghaye J Duchateau RG Grabitz Complement activation during cardiopulmonary bypass in infants and children: relation to postoperative multiple system organ failure J Thorac Cardiovasc Surg 106 1993 978 987
14. WB Smith JR Gamble I Clark-Lewis Interleukin-8 induces neutrophil transendothelial migration Immunology 72 1991 65 72
15. SD Tennenberg WW Bailey LA Cotta The effects of methylprednisolone on complement-mediated neutrophil activation during cardiopulmonary bypass Surgery 100 1986 134 142
16. LW Andersen L Baek BS Thomsen Effect of methylprednisolone on endotoxaemia and complement activation during cardiac surgery J Cardiothorac Anesth 3 1989 544 549
17. NJG Jansen W van Oeveren M van Vliet The role of different types of corticosteroids on the inflammatory mediators in cardiopulmonary bypass Eur J Cardiothorac Surg 5 1991 211 217
18. W Van Oeveren NJG Jansen BP Bidstrup Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass Ann Thorac Surg 44 1987 640 645
19. B Blauhut C Gross S Nececk Effects of high dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass J Thorac Cardiovasc Surg 101 1991 958 967
20. YT Wachtfogel U Kucich CE Hack Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion J Thorac Cardiovasc Surg 106 1993 1 10
21. CH Welsch D Lien GS Worthen Pentoxifylline decreases endotoxin-induced pulmonary neutrophil sequestration in the dog Am Rev Respir Dis 138 1988 1106 1114
22. G Mandell W Novick Proceedings of a symposium: pentoxifylline and leukocyte function. 1988 : Hoechst-Roussel Pharm Inc Somerville, New Jersey 199 210
23. NE Moat PD MacNaughton LCM Pallares Complement inhibition may attenuate acute lung injury after cardiopulmonary bypass in pigs [Abstract] Am Rev Respir Dis 145 1992 A845
24. R Palmer KC. Lasseter Sodium nitroprusside N Engl J Med 292 1975 294 297
25. DG Harrisson JN. Bates The nitrovasodilators: new ideas about old drugs Circulation 87 1993 1461 1467
26. CP Price K Spencer J. Whicker Light-scattering immunoassay of specific proteins: a review Ann Clin Biochem 20 1983 1 14
27. G Servais J Walmagh J. Duchateau Simple quantitative haemolytic microassay for determination of complement alternative pathway activation J lmmunol Methods 140 1991 93 100
28. MM Quiroga R Miyagishima LC Haendschen The effect of body temperature on leukocyte kinetics during cardiopulmonary bypass J Thorac Cardiovasc Surg 90 1985 91 96
29. RE Kalfin RM Engelman JA Rousou Induction of interleukin-8 expression during cardiopulmonary bypass Circulation 88 1993 401 406
30. WP Arnold DE Longnecker RM. Epstein Photodegradation of sodium nitroprusside: biologic activity and cyanide release Anesthesiology 61 1984 254 260
31. JN Bates MT Baker R Guerra Jr Nitric oxide generation from nitroprusside by vascular tissue: evidence that reduction of the nitroprusside anion and cyanide loss are required Biochem Pharmacol 42 Suppl 1991 157 165
32. S Moncada RMJ Palmer A. Higgs Nitric oxide: physiology, pathophysiology, and pharmacology Pharmacol Rev 43 1991 109 142
33. S Moncada A Higgs The L-arginine–nitric oxide pathway N Engl J Med 329 1993 2002 2012
34. E. Anggard Nitric oxide: mediator, murderer and medicine Lancet 343 1994 1199 1206
35. 2 toxicity Proc Natl Acad Sci U S A 89 1992 9715 9719
36. H Abdih CJ Kelly D Bouchier-Hayes Nitric oxide (endothelium-derived relaxing factor) attenuates revascularization-induced lung injury J Surg Res 57 1994 39 43
37. P Kubes M Suzuki DN. Granger Nitric oxide: an endogenous modulator of leukocyte adhesion Physiol Pharmacol 88 1991 4651 4655
38. DJ Lefer K Nakanishi WE Johnston Antineutrophil and myocardial protecting actions of a novel nitric oxide donor after acute myocardial ischemia and reperfusion in dogs Circulation 88 1993 2337 2350
39. MC Seghaye J Duchateau RG Grabitz Perioperative Anwendung von Natriumnitroprussid zur Reduktion von Herz-Lungen-Maschinen-induzierten Komplikationen beim Kind [Abstract] Z Kardiol 81 1992 58
40. TJ Bixler VL Gott TJ. Gardner Reversal of experimental pulmonary hypertension with sodium nitroprusside J Thorac Cardiovasc Surg 81 1981 537 545
41. WJ Paulus PJ Vantripont A. Shah Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans: assessment by bicoronary sodium nitroprusside infusion Circulation 89 1994 2070 2078
42. G Benzig III JA Helmsworth T Schreiber Nitroprusside and epinephrine for treatment of low output in children after open-heart surgery Ann Thorac Surg 27 1979 523 528
43. S Kunathai GF Sholler JM Celermajer Nitroprusside in children after cardiopulmonary bypass: a study of thiocyanate toxicity Pediatr Cardiol 10 1989 121 124